Furthermore, RhoA/ROCK-mediated cytoskeletal contractility is also critical in integrin αvβ6-dependent TGF-β activation [276], influencing various pathophysiological processes such as wound healing, tissue fibrosis, immune responses, cancer progression, and metabolic disorders [213]. Here, TGFB1 is linked to metabolic disease.